@JeanAlexanian Bravo, Jean-Baptiste. Regarde ça aussi: https://t.co/o3K9A99Yhr
RT @psychopharmacol: Meta-analysis: metformin might decrease weight in children/adolescents treated with SGAs vs. placebo after 4, 12, and…
Meta-analysis: metformin might decrease weight in children/adolescents treated with SGAs vs. placebo after 4, 12, and 16 weeks of treatment {SMD= − 0.98 kg (− 1.26, − 0.69); − 1.83 kg (− 2.47, − 1.18); and − 3.23 kg (− 5.59, − 0.86), respectively} https://
RT @psychopharmacol: Meta-analysis: Metformin might decrease weight in children/adolescents treated with SGAs after 4, 12, and 16 weeks of…
Meta-analysis: Metformin might decrease weight in children/adolescents treated with SGAs after 4, 12, and 16 weeks of treatment {MD = − 0.98 kg ;− 1.26, − 0.69); − 1.83 kg (− 2.47, − 1.18); and − 3.23 kg (− 5.59, − 0.86), respectively} https://t.co/BmCc50O
RT @CorteseSamuele: Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence sh…
RT @CorteseSamuele: Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence sh…
RT @CorteseSamuele: Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence sh…
RT @CorteseSamuele: Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence sh…
RT @CorteseSamuele: Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence sh…
Our new meta-analysis on metformin in child and adolescent psychiatry is out in CNS Drugs: "Meta-analytical evidence shows that metformin might decrease weight in children/adolescents treated with SGAs but additional high-quality evidence is needed" https: